Real World Data Programmer (Assoc. Director)

Description

As a member of the CDS-RWE Analytics group, the RWD Analyst reports directly Head of RWE Analytics and is responsible for the design and conduct of statistical analyses of RWD to assess the value of Gilead therapies and perform data visualization and QCs TFLs to communicate results to internal stakeholders in Real World Evidence. The RWD Analyst will align with the Real-World Evidence Therapeutic Area (TA)-aligned Lead to conduct timely, relevant and rigorous analysis of RWD to address critical research questions, as well as collaborate with CDS to develop, refine, and scale data management and analytic procedures, systems, workflows, best practices, and other issues.

Key Responsibilities

Develop and QC TFLs for protocols/reports/manuscripts from RWE research conducted to assess the value of Gilead therapies using RWD (e.g. claims and EHR). QC programming for descriptive and complex studies using RWD. Conduct analyses and develop specifications for descriptive and complex statistics in studies using RWD. Write the statistical analysis plan (SAP) for descriptive and complex studies using RWD, including from internal Gilead-sponsored prospective cohort studies, claims, charge master and EHR in collaboration with RWE TA lead Understand methods and programming to support Comparative Effectiveness Research (CER) analyses, as well as analyses of patient-reported outcomes (PRO) or other patient outcome data Develop and QC TFLs for protocols/reports/manuscripts from RWE research conducted to assess the value of Gilead therapies using RWD (e.g. claims and EHR) Work with RWE researchers to generate code lists for new measures in RWD

Knowledge, Skills and Experience

Master’s degree (e.g. MA, MSc, MPH) inBiostatistics, Epidemiology or related discipline, such as Outcomes Research from an accredited institution, with an extensive background of relevant, post-graduation experience. Doctoral level training with relevant experience is preferred. Direct experience in lieu of academic training is acceptable. Knowledge of real-world data and experience in observational research study design, execution and communication. Strong track record of analysis of a broad range of RWD. Formal training in Programming and demonstrated proficiency in statisticalanalysis programs commonly used in life sciences (e.g. SAS, R).Understanding of epidemiology or outcomes research and the application of retrospective or prospective studies to generate value evidence. Ability to effectively communicate statistical methodology and analysis results. Ability to work effectively in a constantly changing, diverse, and matrix environment. Knowledge of US secondary data sources required; additional experience with international data sources is preferred. Knowledge and experience in qualitative analysis and data sets (e.g., free-text natural language processing, survey data) is preferred.

Equal Employment Opportunity (EEO)

It is the policy of Gilead Sciences, Inc. and its subsidiaries and affiliates (collectively "Gilead" or the "Company") to recruit select and employ the most qualified persons available for positions throughout the Company. Except if otherwise provided by applicable law, all employment actions relating to issues such as compensation, benefits, transfers, layoffs, returns from layoffs, company-sponsored training, education assistance, social and recreational programs are administered on a non-discriminatory basis (i.e. without regard to protected characteristics or prohibited grounds, which may include an individual’s gender, race, color, national origin, ancestry, religion, creed, physical or mental disability, marital status, sexual orientation, medical condition, veteran status, and age, unless such protection is prohibited by federal, state, municipal, provincial, local or other applicable laws). Gilead also prohibits discrimination based on any other characteristics protected by applicable laws.

For Current Gilead Employees and Contractors:

Please log onto your to apply for this job.